Air India launches Delhi-Washington flight
State-owned Air India on Thursday launched its first flight to Washington DC from New Delhi, thereby adding its fifth destination in the US.
Air India has deployed its 238-seater Boeing 777-200 LR aircraft to cater to the new direct service to the US. The plane offers eight seats in first class, 35 in business and 195 in economy class.
The launch took place at the Indira Gandhi International (IGI) Airport here in the presence of Charge de Affairs of US Embassy Marykay Loss Carlson, Air India chairman and managing director Ashwani Lohani, commercial director of Air India Pankaj Shrivastava, among other airline officials.
Indian ambassador to the US Navtej Sarna, Lohani and Srivastava are also flying to Washington. The occupancy on flights to Washington is at 90 per cent for the month of July, according to the airline spokesperson. The airline will operate a bigger 321-seater Boeing 777- 300ER aircraft between July 9 and 17, he said.
Washington is the the fifth destination for Air India. The service to the US capital will be offered three times a week. Apart from Washington, Air India flies to four US airports – New York, Newark, Chicago and San Francisco. There are daily flights to Newark, New York and Chicago. However, its Delhi-San Francisco flight is operated six times a week.
You might also like
MMPRC appoints TRAC Representations as its Marketing Representative in India
Maldives Marketing & Public Relations Corporation Limited (MMPRC) appoints TRAC Representations as its Marketing Representative in India. By the white sand, near the sea, what a dreamy place to be;
UK influencers in Argentina
Four Instagram celebrities toured Buenos Aires, San Antonio de Areco and Mendoza. The Ministry of Tourism of the Nation, through the National Institute of Tourism (INPROTUR), accompanied four important personalities from the social network Instagram UK
Saudi recognizes Covishield as approved vaccine for travel
As Saudi continues to open up to the world, the Saudi Arabian government has recognized Covishield as an approved Covid-19 vaccine. Following this announcement, Covishield, produced by the Serum Institute


